Janus Henderson Investors US’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Janus Henderson Investors US’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-168,954	Closed	-$10.5M	–	1242
2016 Q3	$10.5M	Sell	168,954 -26,851	-14%	-$1.9M	0.01%	685
2016 Q2	$11.1M	Sell	195,805 -40,751	-17%	-$2.48M	0.01%	658
2016 Q1	$15.2M	Sell	236,556 -120,394	-34%	-$9.74M	0.01%	610
2015 Q4	$50.2M	Hold	356,950	–	–	0.04%	418
2015 Q3	$32.8M	Buy	+356,950	New	+$42.5M	0.03%	500

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Investors US's KDNY Position: Q4 2016 in Review

Janus Henderson Investors US sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2016, closing a stake of 168,954 shares — an estimated $10.5M sold.

Janus Henderson Investors US first reported a position in KDNY in Q3 2015 and held it in 5 quarters. The position peaked at $50.2M in Q4 2015. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2016.

Janus Henderson Investors US reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Janus Henderson Investors US sold 168,954 Chinook Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $10.5M.
Janus Henderson Investors US first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
Janus Henderson Investors US's Chinook Therapeutics, Inc. Common Stock position peaked at $50.2M in Q4 2015.
87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Janus Henderson Investors US's 13F filing for Q4 2016, filed 14 Feb 2017.